UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037639
Receipt number R000042919
Scientific Title Effects of rice on blood glucose level : study 1
Date of disclosure of the study information 2019/08/16
Last modified on 2020/02/20 13:51:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of rice on blood glucose level :
study 1

Acronym

Effects of rice on blood glucose level :
study 1

Scientific Title

Effects of rice on blood glucose level :
study 1

Scientific Title:Acronym

Effects of rice on blood glucose level :
study 1

Region

Japan


Condition

Condition

healthy adult male

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study examines effects of rice on blood glucose level.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Glycemic Index (GI)

Key secondary outcomes

Incremental area under the blood glucose response curve (IAUC)
Peak of blood glucose level
Transition of blood glucose level
Questionnaires of test food


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

standard rice, rice1, rice6, rice5, rice4, rice3, rice2

Interventions/Control_2

standard rice, rice2, rice1, rice6, rice5, rice4, rice3

Interventions/Control_3

standard rice, rice3, rice2, rice1, rice6, rice5, rice4

Interventions/Control_4

standard rice, rice4, rice3, rice2, rice1, rice6, rice5

Interventions/Control_5

standard rice, rice5, rice4, rice3, rice2, rice1, rice6

Interventions/Control_6

standard rice, rice6, rice5, rice4, rice3, rice2, rice1

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male

Key inclusion criteria

1.Japanese healthy men aged 20-50years
2.BMI of 20-25 kg/m2
3.Individuals who can visit hospital on specified days
4.Individuals whose written informed consent has been obtained

Key exclusion criteria

1.Individuals who have allergic reaction to rice, wheat, barley, egg and milk
2.Individuals who have history of severe disorder and surgical disorder
3.Individuals who have medical disorder, cardiovascular, hepatic and kidney disorder, including complication of other disorder in preliminary examination
4.Individuals suspected of infectious disorder from results immunological examination
5.Individuals who have presence or previous history of gastrointestinal disease, or surgical history for excision of the gastrointestinal tract, gastric ulcer, peptic ulcer etc.
6.Individuals who have history of thyroid disorder
7.Individuals whose fasting glucose level are not 70-109 mg/dL
8.Individuals who have a difference within 25% in the IAUC of two preliminary examinations
9.Individuals diagnosed as impaired glucose tolerance in the past year
10.Individuals who donated blood (blood donation etc.) exceeding 200 mL within 4 weeks, 400 mL within 4 months or, 1200 mL within 12 months
11.Individuals participating in any other long clinical study involving human subjects within 4 weeks or currently participating in any other clinical study involving human subjects.
12.Individuals with excessive alcohol drinking or smokers
13.Individuals who can not eat regularly
14.Individuals currently intaking medicine, health food product or a supplement
15.Individuals who have experienced a feeling of unwellness or bad physical condition by blood drawing.
16.Individuals judged inappropriate for the trial by the principal

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Tomoyuki
Middle name
Last name Mine

Organization

Ajinomoto Co., Inc

Division name

Human health & nutrition group, Institute of food sciences & technologies

Zip code

2108681

Address

1-1, Suzuki-tyo, Kawasaki-ku, Kawasaki-shi, Kanagawa

TEL

044-223-4114

Email

tomoyuki_mine@ajinomoto.com


Public contact

Name of contact person

1st name Naoko
Middle name
Last name Fujimura

Organization

Ajinomoto Co., Inc

Division name

Human health & nutrition group, Institute of food sciences & technologies

Zip code

2108681

Address

1-1, Suzuki-tyo, Kawasaki-ku, Kawasaki-shi, Kanagawa

TEL

044-223-4114

Homepage URL


Email

naoko_fujimura@ajinomoto.com


Sponsor or person

Institute

Medical Corporation Hokubukai Utsukushigaoka Hospital

Institute

Department

Personal name



Funding Source

Organization

Ajinomoto Co., Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Clinical Support Corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Hokubukai Utsukushigaoka Hospital ethical review committee

Address

61-1, Shinei, Kiyota-ku, Sapporo-shi, Hokkaido

Tel

011-882-0111

Email

info@csc-smo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人 北武会 美しが丘病院


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 15 Day

Date of IRB

2019 Year 08 Month 15 Day

Anticipated trial start date

2019 Year 08 Month 16 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 08 Day

Last modified on

2020 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042919


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name